TY - JOUR KW - Noma KW - cancrum oris KW - children's rights KW - health disparities KW - infectious diseases in poverty KW - malnutrition KW - Neglected tropical diseases (NTDs) KW - orofacial gangrene KW - Sub-Saharan Africa KW - WHO recognition AU - Satapathy P AU - Rustagi S AU - Kumar P AU - Khatib MN AU - Gaidhane S AU - Zahiruddin QS AU - Gaidhane AM AU - Neyazi M AU - Neyazi A AB -

The World Health Organization's (WHO) designation of noma as a neglected tropical disease (NTD) on 15 December 2023 marks a crucial advancement in global health efforts. This move sheds light on a condition predominantly affecting undernourished children in isolated regions of sub-Saharan Africa. Recognized as the 21st NTD, noma, or cancrum oris, is a serious condition leading to orofacial gangrene. The disease largely impacts young children and those with compromised immune systems, including individuals with human immunodeficiency virus or leukaemia. Determining the exact prevalence of noma is complex, hindered by rapid disease progression, societal stigma and a lack of reporting, especially in impoverished areas. The WHO's acknowledgment is a significant step, emphasizing the need for more in-depth research and resources to address this overlooked disease. It highlights the critical role of multifaceted prevention strategies, including economic empowerment, improved nutrition and enhanced vaccination efforts. This recognition is pivotal in guiding international health initiatives towards better outcomes for some of the most at-risk populations globally.

BT - Transactions of The Royal Society of Tropical Medicine and Hygiene DO - 10.1093/trstmh/trae031 LA - Eng N2 -

The World Health Organization's (WHO) designation of noma as a neglected tropical disease (NTD) on 15 December 2023 marks a crucial advancement in global health efforts. This move sheds light on a condition predominantly affecting undernourished children in isolated regions of sub-Saharan Africa. Recognized as the 21st NTD, noma, or cancrum oris, is a serious condition leading to orofacial gangrene. The disease largely impacts young children and those with compromised immune systems, including individuals with human immunodeficiency virus or leukaemia. Determining the exact prevalence of noma is complex, hindered by rapid disease progression, societal stigma and a lack of reporting, especially in impoverished areas. The WHO's acknowledgment is a significant step, emphasizing the need for more in-depth research and resources to address this overlooked disease. It highlights the critical role of multifaceted prevention strategies, including economic empowerment, improved nutrition and enhanced vaccination efforts. This recognition is pivotal in guiding international health initiatives towards better outcomes for some of the most at-risk populations globally.

PB - Oxford University Press (OUP) PY - 2024 T2 - Transactions of The Royal Society of Tropical Medicine and Hygiene TI - Understanding noma: WHO's recognition and the path forward in global health SN - 0035-9203, 1878-3503 ER -